GHK-Cu 5mg — Vial Spec, Reconstitution Math & COA

Overview of GHK-Cu 5mg Vial Specifications and Research Applications

The 5mg unit specification of GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is designed specifically for quantitative biochemical research where precise working concentrations are required without subjecting large stock quantities to repeated degradation. Each vial contains lyophilized GHK-Cu tripeptide bound to divalent copper (Cu2+), appearing as a distinct blue powder due to the coordination complex of the transition metal with the histidine residue.

Principal investigators and laboratory technicians typically select the 5mg mass format when conducting low-volume cell culture treatments, spectrophotometric quantification, or ELISA assays. Purchasing research peptides in 5mg unit masses allows research teams to reconstitute fresh working aliquots on an as-needed basis. This minimizes peptide hydrolysis and loss of copper chelation over extended experimental runs.

Chemical Structure, Chelation Dynamics, and Molecular Weight

GHK-Cu is a naturally occurring tripeptide-copper complex with the chemical formula C14H24CuN6O4 and a molecular weight of approximately 403.93 g/mol. The peptide sequence consists of glycyl-L-histidyl-L-lysine, which exhibits an extraordinarily high binding affinity for copper ions (log K = 16.4). This tight chelation allows the molecule to act as a copper transport vector within extracellular matrix (ECM) microenvironments in laboratory models.

In analytical chemistry settings, maintaining the structural integrity of the copper-peptide complex requires control of pH and solvent selection. When evaluating GHK-Cu mechanism and biochemistry, researchers note that acidic environments below pH 4.0 can cause protonation of the histidine imidazole ring, leading to the dissociation of the Cu2+ ion. Consequently, reconstitution in buffered solutions at physiological pH (7.2–7.4) is critical for preserving target reactivity during in vitro evaluation.

Preclinical Research Focus: Collagen, Elastin, and Matrix Remodeling

In vitro and animal models demonstrate that GHK-Cu plays a central role in modulating extracellular matrix synthesis and cellular repair pathways. Preclinical studies suggest that GHK-Cu upregulates expression of collagen Type I and Type III mRNA in cultured human dermal fibroblasts, while simultaneously stimulating elastin production. These mechanisms are primary focus areas in tissue engineering and wound closure research.

Furthermore, in vitro data indicate that GHK-Cu regulates matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). By balancing MMP-1 and MMP-2 activity with TIMP-1 release, the compound demonstrates a capacity to promote organized matrix remodeling while reducing excess fibrotic scarring in wound healing models. Research models evaluating skin remodeling pathways frequently examine these gene expression profiles to quantify cellular repair velocity.

Reconstitution Math: Concentration Values for 5mg Vials

Achieving exact target concentrations requires precise volumetric calculation based on the total 5mg lyophilized mass. Reconstituting a 5mg GHK-Cu vial with sterile diluent (such as Bacteriostatic Water or Phosphate-Buffered Saline) yields specific mass-per-volume concentrations depending on diluent additions:

1.0 mL Diluent Addition: Adding 1.0 mL of diluent to 5 mg of peptide yields a final concentration of 5.0 mg/mL (5000 µg/mL or 5 µg/µL). 2.0 mL Diluent Addition: Adding 2.0 mL of diluent to 5 mg of peptide yields a final concentration of 2.5 mg/mL (2500 µg/mL or 2.5 µg/µL). 3.0 mL Diluent Addition: Adding 3.0 mL of diluent to 5 mg of peptide yields a final concentration of 1.67 mg/mL (1667 µg/mL or 1.67 µg/µL).

For complex dilution schemes or multi-well plate preparation, researchers can utilize our automated reconstitution calculator to quickly calculate aliquot volumes for specific microgram-per-well concentrations.

Aliquot Management and Thermal Storage Protocols

Lyophilized GHK-Cu 5mg vials must be stored in a controlled environment to ensure long-term stability. Unreconstituted vials should be kept at -20°C for short-to-medium storage (up to 12 months) or -80°C for long-term storage, protected from light exposure. Proper storage prevents moisture absorption and maintains powder integrity prior to liquid reconstitution.

Once reconstituted with liquid diluent, GHK-Cu stock solutions should be divided into single-use analytical aliquots using sterile polypropylene microcentrifuge tubes. Freeze-thaw cycles must be strictly avoided, as repeated thermal transitions induce peptide cleavage and copper ion detachment. Reconstituted aliquots stored at 4°C are stable for up to 14–28 days depending on diluent sterility, while aliquots frozen at -20°C maintain high activity for up to 90 days. Refer to our general peptide storage guide for comprehensive facility protocols.

Lot-Matched Certificate of Analysis (COA) Verification

Every production lot of GHK-Cu undergoes rigorous analytical testing to verify sequence identity, purity, and freedom from contaminants. Every shipment includes access to a lot-matched Certificate of Analysis (COA) detailing full analytical breakdown.

PX1 Research utilizes High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeding 99.0%, alongside Mass Spectrometry (MS) to verify precise molecular mass. Additionally, all lots undergo chromogenic LAL assays to ensure endotoxin levels remain strictly below <0.05 EU/mg, meeting stringent ISO 17025 laboratory standards. Researchers can cross-reference batch numbers on their 5mg vials directly against our public database to verify chemical compliance.

Comparative Analysis: GHK-Cu vs. Matrix-Active Research Peptides

When designing tissue repair and extracellular matrix experiments, investigators often compare GHK-Cu to other matrix-active research compounds. While GHK-Cu focuses heavily on copper-mediated enzyme modulation and gene transcription, alternative research peptides operate through distinct signal cascades:

For instance, researchers evaluating tissue regeneration pathways often contrast the copper peptide GHK-Cu with synthetic signaling peptides such as BPC-157. While GHK-Cu directly stimulates fibroblast collagen synthesis and matrix turnover, compounds like BPC-157 5mg are studied for VEGFR2 pathway stimulation and cell migration dynamics. Combining or comparing these agents within in vitro wound healing assays allows laboratories to map complementary repair mechanisms across different cellular matrices.

Vial Size Strategy: Selecting Between 5mg and Alternative Formats

Choosing the optimal vial mass depends directly on your laboratory's experimental throughput and assay design. The 5mg format is optimal for exploratory studies, low-density microplate assays, or single-assay series where minimizing reagent age is critical. For higher-throughput screening or multi-animal preclinical cohorts, larger unit sizes reduce per-milligram costs and minimize vial-to-vial reconstitutions.

PX1 Research provides GHK-Cu across several fill sizes to accommodate varying scale requirements. If your protocol requires larger bulk volumes beyond the 5mg specification, view our standard catalog listing for GHK-Cu or contact our team for wholesale and bulk lab accounts to request custom batch packaging.

Handling and Dissolution Instructions for In Vitro Assays

To achieve complete solubilization without damaging the peptide matrix, laboratory personnel should follow standardized reconstitution practices. Allow the GHK-Cu 5mg vial to equilibrate to room temperature before removing the cap to prevent moisture condensation inside the glass vial.

Using a sterile syringe, slowly introduce the calculated volume of diluent down the inner glass wall of the vial rather than shooting liquid directly onto the lyophilized pellet. Gently swirl the vial in a circular motion until the blue powder is fully dissolved. Avoid vigorous vortexing or agitation, as shearing forces and excess bubbling can induce peptide denaturation or destabilize the copper complex.